Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
57,285,340
-
Total 13F shares
-
47,330,397
-
Share change
-
+2,243,311
-
Total reported value
-
$2,039,414,220
-
Put/Call ratio
-
64%
-
Price per share
-
$43.10
-
Number of holders
-
262
-
Value change
-
+$105,035,296
-
Number of buys
-
142
-
Number of sells
-
119
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q2 2017
As of 30 Jun 2017,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by
262 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,330,397 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., ACADIAN ASSET MANAGEMENT LLC, Bank of New York Mellon Corp, STATE STREET CORP, RICE HALL JAMES & ASSOCIATES, LLC, DIMENSIONAL FUND ADVISORS LP, ROTHSCHILD ASSET MANAGEMENT INC, and Ranger Investment Management, L.P..
This page lists
262
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.